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Changes in carbon monoxide transfer over 22 years
in middle-aged men
A. WATSON, H. JOYCE AND N. B. PRIDE
Respiratory Medicine NHLI, Imperial College School of Medicine, Hammersmith Campus, Ducane Road,
London W12 ONN, U.K.
We measured single breath CO transfer (TLco), single breath alveolar volume (VA), CO transfer coecient (KCO)
and forced expiratory volume in 1 sec (FEV1) in 84 men, mean age 40?5 years at recruitment, in 1975 and in 1997.
At recruitment, 42 men were cigarette smokers and 42 were not smoking. Mean annual decline in FEV1 was similar
in never- (34?2 ml yr71) and ex- (33?1 ml yr71) smokers and faster (51?0 ml yr71) in continuing smokers.
In contrast to predictions from cross-sectional reference values, there was no fall in TLco or Kco in men who did
not smoke over the period of follow-up. In the 16 men who smoked throughout follow-up there was a 10% fall in
TLco (P= 0?043) but most of this was due to a significant fall in VA (P= 0?017), presumably reflecting uneven gas
mixing.
These results indicate the need for population-based longitudinal studies of TLco and KCO. If single breath
estimates of VA are used in subjects with even mild airflow obstruction, KCO rather than TLco should be used to
assess alveolar function.
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Tests of lung function used in epidemiological surveys,
predominantly tests of maximum expiratory flow, reflect
either airway function alone or a combinaton of airway and
alveolar function; the single breath carbon monoxide
transfer test is the only widely applied test with the
potential to follow alveolar function.
Cross-sectional data currently are used to obtain
reference values for all pulmonary function tests. Reference
values for spirometry are considerably more consistent and
explain a greater part of the between subject variability
than available reference values for carbon monoxide
transfer (1,2). Even so, when longitudinal changes in
spirometry have been directly observed, decline in spiro-
metry with increasing age has usually been smaller than
expected from reference values, suggesting a favourable
cohort effect (3–5). Observations on longitudinal changes in
carbon monoxide transfer factor (TLco) are sparse (6,7) and
not available for the carbon monoxide transfer coecient
(KCO), reflecting the more limited application of the test and
its greater complexity.Received 10 April 2000 and accepted in revised form 22 June 2000.
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0954-6111/00/111103+06 $35?00/0We have recently restudied TLco, KCO and spirometry in
84 men after an interval of 22 years. These men were in
early middle age at recruitment; their smoking habits and
clinical history were extensively documented during follow-
up, so that the major factors expected to influence
pulmonary function in this relatively homogenous group
of middle aged men were known. The observed changes in
TLco and KCO with increasing age were much less than
predicted from cross-sectional studies.
Materials and methods
SUBJECTS
Subjects were white middle-aged men, who were mainly
oce workers working and living in West London,
originally recruited into a longitudinal study in 1975 and
seen at regular intervals subsequently (8). In 1997 all
available men were studied again, but the present analysis is
confined to those with a consistent history of cigarette
smoking (or non-smoking) habit as assessed by repeated
questionnaires and measurements of expired CO during the
follow-up period. Apart from men with erratic smoking
habits, we excluded men with disease likely to interfere with
lung function (assessed by questionnaires, reports from the
subjects’ own medical practitioners and chest radiographs)
and those taking b-adrenoceptor blocking drugs. All the 84
men who fulfilled these criteria are included in this report.
Forty-two men were not smoking at recruitment in 1975 (29# 2000 HARCOURT PUBLISHERS LTD
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ex-smokers (XS) of 11 pack-years) and did not smoke
during follow-up to 1997. The remaining men were
cigarette smokers in 1975: 26 of these men gave up at
varying times during follow-up to 1997 and were subse-
quently sustained quitters (QS). The remaining 16 men
smoked an average of 20?9 (range 6–48) cigarettes per day
throughout the period 1975–1997 (S). Age and height were
similar in the four groups (Table 1).
MEASUREMENTS
TLco was measured using the standard single breath
method at full inflation. All details of the apparatus were
as similar as possible and the method and calculations were
identical in years 0 and 22. Alveolar volume (VA) during
breathholding was measured from the single breath dilution
of helium; the apparatus and estimated anatomical dead-
space (VD anat) were subtracted from the inspired volume
on the assumption that deadspace VD anat (ml)=a-
ge(years)þweight (lb) of each man. A correction was
applied to the expired gas concentration to allow for
absorption of carbon dioxide (assumed to be 5%) from the
expired sample before its analysis. On both occasions
haemoglobin was measured and the TLco results were
corrected to a standard haemoglobin concentration of
14?3 g dl71. VA is reported in litres BTPS and converted to
ml STPD for use in calculation of TLco. Results were
also expressed as carbon monoxide transfer coecient
(Kco) by dividing TLco by VA BTPS. The results reported
are the mean of calculations made on two acceptable
breaths. The details of the technique corresponded closely
to the recommendations of the American Thoracic
Society (9). Values were also expressed as percentage of
reference values (10).
At the time of the first measurement of TLco each subject
had carboxyhaemoglobin measured in the venous blood
using the spectrophotometer method. During follow-up and
at the end of the 22 years the end-expired alveolar con-
centration of CO(FACO) was measured by a long slow expira-
tion to residual volume into a CO analyser (Bedfont, U.K.).
Forced expiratory volume in 1 sec (FEV1) and slow vital
capacity (VC) were measured with a dry spirometer andTABLE 1. Initial characteristics and smoking history [mean (SD)
n Age (years) Height (cm) Weight (k
1975 1975 1975
NS 29 37?1 (9?8) 177 (7?4) 73 (6) 8
XS 13 39?3 (11?9) 177 (6?7) 75 (11) 8
QS 26 43?1 (9?6) 177 (6?9) 77 (11) 8
S 16 42?4 (10?8) 176 (8?2) 76 (11) 8
*Converted to ppm from values of carboxyhaemoglobin obtain
Definitions of smoking subgroups: NS: never-smokers; XS: men
QS: smokers who gave up after 1975 and subsequently were suexpressed at BTPS and on each occasion the largest of three
satisfactory measurements was taken. Values were com-
pared with European community reference values (2).
STATISTICS
Unpaired t-tests were used to compare subgroups; paired t-
tests to assess changes with time in subgroups.
Results
CHANGES IN FEV1 (TABLE 2)
Initial values of FEV1 in NS were slightly higher than in XS
but over the 22 years of follow-up decline in the two groups
was virtually identical. Men in the S group had lower initial
values of FEV1 and showed faster decline in FEV1 than NS,
(P=0?0002) and XS (P=0?0021). There was a weak
relation between rapid decline in FEV1 and pack-years of
smoking during follow-up. Men in the QS group had
similar initial FEV1 to the S group but their subsequent
decline, although slightly faster than in NS and XS, was still
significantly slower than in S (P=0?0275).
CHANGES IN CARBON MONOXIDE
TRANSFER (TABLE 3)
Initial values of TLco and KCO were lower in the two groups
smoking at recruitment (S, QS) than in those not smoking
(NS, XS). During follow-up there were no significant
changes in TLco, KCO or VA in NS (Fig. 1) and XS. In
smokers there was a significant fall in VA (P=0?017) and
TLco (P=0?043) during follow-up but not in KCO (P=0?69).
There was no relation between fall in TLCO and pack-years
smoked during follow-up but there was a weak trend for
fall in TLco to be largest in smokers with the most rapid
decline in FEV1 (r
2=0?27, P=0?0001). In quitting smokers,
who had similar initial values of TLco and KCO to smokers,
there was no change during follow-up although the mean
fall of VA of 0?23 l was significant (P=0?038).]
g) pack-years FACO (ppm)
1997 1975 1997 1975* 1997
0 (12) 2?7 (1?4) 4?3 (1?7)
0 (14) 7 (9) 7 (9) 2?2 (0?7) 3?6 (1?3)
6 (14) 23 (12) 29 (17) 13?4 (9?2) 4?5 (1?7)
2 (15) 25 (16) 47 (24) 20?1 (9?0) 18?7 (10?7)
ed in 1975.
who were ex-smokers in 1975 and did not smoke 1975–1997;
stained quitters; S: men who smoked throughout 1975–1997.
TABLE 2. Changes in FEV1 during follow-up [Mean (SD)]
FEV1 DFEV1 FEV1/VC
litres % predicted (ml y)71 (%)
n 1975 1997 1975 1997 1975–1997 1975 1997
NS 29 4?41 (0?8) 3?65 (0?8) 112 (11) 112 (16) 34?2 (12) 76 (8) 74 (6)
XS 13 4?06 (0?8) 3?37 (0?8) 106 (13) 105 (17) 33?1 (10) 75 (6) 72 (7)
QS 26 3?71 (0?7) 2?86 (0?7) 100 (17) 95 (22) 38?8 (17) 70 (10) 66 (13)
S 16 3?68 (0?7) 2?55 (0?7) 100 (8) 85 (14) 51?0 (16) 72 (5) 64 (11)
Definitions of smoking subgroups—see Table 1.
TABLE 3. Changes in CO transfer during follow-up [Mean (SD)]
VA litres TLco mmol min
71
kPa71 [% predicted]
KCO mmol min
71
kPa71 l71 [% predicted]
n 1975 1997 1975 1997 1975 1997
NS 29 6?77 (0?9) 6?95 (1?1) 10?86 (1?5) 11?24 (1?7) 1?62 (0?2) 1?64 (0?2)
[99] [124] [97] [122]
XS 13 6?50 (1?0) 6?56 (1?1) 11?12 (2?0) 11?73 (2?9) 1?72 (0?3) 1?78 (0?3)
[102] [130] [105] [136]
QS 26 6?65 (0?8) 6?42 (0?7) 9?04 (1?7) 9?11 (2?4) 1?38 (0?3) 1?42 (0?4)
[86] [106] [86] [112]
S 16 6?40 (0?9) 5?95 (1?0) 9?05 (1?7) 8?13 (2?1) 1?42 (0?2) 1?39 (0?3)
[88] [97] [89] [109]
Definitions of smoking subgroups—see Table 1.
CHANGES IN CO TRANSFER OVER 22 YEARS 1105Discussion
Falls in FEV1 with increasing age were found in all four
groups of men; these falls varied appropriately with the
smoking history during follow-up. In contrast there were
no falls over 22 years in mean TLco or KCO in the NS, QS
and XS groups. Even in continuing smokers the 10% fall in
TLco was less than predicted from available reference values
and was mainly due to a 7% fall in VA.
CRITIQUE OF SELECTION OF SUBJECTS
AND METHODS
We are not aware of any previous longitudinal data on KCO
derived from population studies, while the longest popula-
tion-derived follow-up data on TLco was obtained after an
8-year interval (6). The strengths of the present, admittedly
limited, data are the long follow-up in a relatively
homogenous group of middle-aged men who were experi-
enced in performing lung function tests, had no relevant
occupational exposures and whose smoking, clinical and
therapeutic histories were well characterized. While the
coaching of the individuals, method, calibrations and
calculations remained unchanged over the follow-up periodwe inevitably cannot exclude a period effect. When surveys
are repeated at short intervals unexplained small biases in
spirometry are observed (3) which may have considerable
influence on longitudinal trends measured over a few years.
Indeed, in an earlier 10-year follow-up from this laboratory
(11), which included some of the men in the present study,
we found an average 7% fall in KCO in never-smokers, but
such survey biases have progressively less effect as follow-
up is prolonged. Direct evidence that the helium dilution
technique was accurate over this period was obtained from
the lack of change in VA in NS. Initial values of TLco and
KCO in NS and XS were close to the reference values we
used, but the lack of fall in absolute values obviously led to
a rise in values expressed as percent predicted in 1997,
which would be found regardless of which reference values
were chosen. For instance, using Cotes’ predictions (12)
mean TLco in NS was 100% predicted in 1975 and 116%
predicted in 1997, and in S was 87% predicted in 1975 and
91% predicted in 1997. Corrections were made for Hb but
not for CO back-pressure, although this would only have a
differential effect for QS group (adjusted mean values for
TLco 9?12 in 1975 and 9?14 in 1997 cf. Table 3). Values of
alveolar CO in NS, XS and QS (after quitting) were similar
confirming the reported smoking history. Even though the
continuing smokers are a highly selected group of the
FIG. 1. Individual values of alveolar volume (VA), carbon monoxide transfer factor (TLco) and carbon monoxide transfer
coecient (KCO) in never-smokers at the beginning (1975) and (1997) end of follow-up. Open square and bars indicate
mean+SD.
1106 A. WATSON ET AL.smokers originally seen in 1975 (with many being excluded
by disease or quitting during follow-up) their accelerated
mean decline in FEV1 (Table 2) is similar to that reported
from many other studies.
POTENTIAL MECHANISMS OF CHANGE
IN CO TRANSFER WITH NORMAL AGING
TLco is the product of two primary measurements—the VA
at which CO uptake is measured (full inflation in the
standard single breath technique) and the KCO which
essentially is the rate-constant for alveolar-capillary CO
transfer and only differs from the original Krogh coecient
by constant factors (STPD to BTPS conversion and
barometric pressure), which do not vary with age. Because
total lung capacity (TLC) does not change with increasing
age in normal subjects (2), as confirmed in the present study
by the lack of change in VA in NS, any normal aging change
in TLco must occur in KCO.
KCO is determined by the available airspace surface area,
the thickness of the alveolar–capillary barrier [which
together represent the membrane (DM) component in the
Roughton-Forster analysis (13)] and the pulmonary capil-
lary volume (QC). Although one study showed that alveolar
wall thickness was slightly increased in the senile lung at
post mortem (14) the precise site and nature of thickening
was not determined so its effect on gas transfer is unknown.
Several morphological studies agree that the total surface
area of airspace wall per unit of lung volume at full inflation
decreases by about 0?5% per year throughout adult life
(15–17). However, the relevant surface area for gas uptake
is not the whole membrane but the part that is backed by
capillary blood (QC) (18). Thus when cardiac output
increases during exercise, QC at a given alveolar volume
increases by capillary distension and recruitment; as a result
DM also increases and in healthy subjects TLco increases bymore than 50%, indicating a considerable physiological
reserve of surface area (19). With increasing age there may
be more even perfusion of the lung (20), while resting
cardiac output, microvascular density of the alveolar wall
assessed at autopsy (21), and QC show no clear aging
change in cross-sectional studies. Hence preservation of
resting KCO with increasing age might be achieved by
utilizing a greater proportion of the diminished morpholo-
gical surface area. This proposal emphasizes that, unlike
post-bronchodilator FEV1, TLco measured at rest is not a
maximum capacity; the first change due to aging (or indeed
disease) in TLco and KCO is likely to be a decrease in the
values obtained on maximum exercise (19).
SPIROMETRIC CHANGES
The similar rates of decline in FEV1 in the NS and XS
groups confirm that giving up smoking at an early stage
may restore a normal subsequent rate of decline in FEV1.
The responses of smokers who quit after more pack-years
with more impairment of FEV1 is less certain and some
believe if airway inflammation persists FEV1 decline may
remain abnormal. The slightly faster decline in QS than in
NS in the present study, however, could be explained
because smoking continued for part of the follow-up
period. A recent report has suggested that continuing
airway inflammation in ex-smokers may be detected by an
increased FAco (22), so it is reassuring that FAco was similar
in our NS, XS and QS groups.
DETECTING ALVEOLAR DISEASE USING
CO TRANSFER IN SMOKERS/AIRFLOW
OBSTRUCTION
Measurements of CO transfer are often used to detect
evidence of alveolar disease in subjects with airflow
CHANGES IN CO TRANSFER OVER 22 YEARS 1107obstruction but there are several factors which have to be
taken into account in interpretation. In smokers, apart
from the well known reduction in CO transfer due to the
back pressure of CO in the blood, there is an additional
small reduction in KCO and TLco (11, 23), which reverses in
the first weeks after quitting [presumably due to an effect on
the pulmonary vasculature (24)] and potentially can be
allowed for by using appropriate reference values (23). A
further problem arises when VA is derived from the single
breath dilution of helium (VA,SB), because VA,SB diverges
progressively from TLC as airflow obstruction develops (as
implied by the fall in VA in the present smokers with mild
obstruction) (25). Because this fall in VA,SB reflects
impaired gas mixing, this may be due to airway rather
than alveolar disease. This problem can be overcome by
using a multi-breath gas dilution method to derive residual
volume and (hence VA) as recommended by the European
Respiratory Society (2), but this is often not done largely
because of the extra time involved. Alternatively KCO alone
can be used to assess alveolar disease.
In conclusion, the falls in TLco and KCO with aging
predicted from cross-sectional reference values were not
found in middle-aged NS and XS over a period of 22 years,
emphasizing the need for larger long-term longitudinal
studies. The small fall in TLco we observed in continuing
smokers was mainly due to the fall in VA,SB. If VA,SB is used
in subjects with airflow obstruction, the results for TLco and
KCO are likely to be increasingly divergent, with KCO
providing the better estimate of alveolar function.
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